U.S.-Israel Medical Innovation: Advances in Clinical Oncology
May 31st, 2013, 10:45-12:45, hosted at Dentons at the Willis Tower in downtown Chicago
The U.S.-Israel Medical Innovation: Advances in Clinical Oncology meeting is meant to provide two select Israeli companies an opportunity to have a high-level discussion about new technologies from Israel, and learn from healthcare and life science professionals in the U.S about challenges, synergies and opportunities for increased R&D cooperation and business partnerships between Israel and the U.S.
This special event is co-led by the America-Israel Chamber of Commerce Chicago, the American Israel Public Affairs Committee (AIPAC), the Government of Israel Economic Mission, and the Chicago Life Sciences Consortium. The meeting takes place as an independent event during the ASCO Annual Meeting in Chicago.
We have two exciting Israeli companies participating, each pharmaceutical companies focused on treatments for inflammatory diseases and cancer.
These companies will be joined by leading pharmaceutical and biotech companies from around the U.S. and world, including the Global Head, Oncology Strategy from Astellas Pharmaceuticals, as well investors from high profile firms throughout the country and doctors from Rush, the University of Chicago, Northwestern and more.
For more information contact Daniel Blumenthal, Deputy Consul for Economic Affairs, Government of Israel Economic Mission in Chicago.
- 10:45 am: Networking
- 11:00 am: Welcome and Introductions
- 11:10 am: Panel on R&D Cooperation
- 12:00 pm: Lunch and Israeli Company presentations with Q&A